Skip to content
healthcare.dev

Carbidopa and Levodopa

NDC 62332-332, Carbidopa and Levodopa, tablet, extended release, from Alembic Pharmaceuticals Inc..

Product NDC
62332-332
Status
Listed
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA210341
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/62332-332 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CARBIDOPA25 mg/1
  • LEVODOPA100 mg/1

Pharmacologic classes

Amino Acids, Aromatic [CS]; Aromatic Amino Acid [EPC]

Package NDCNDC-11Package
62332-332-306233203323030 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-30)
62332-332-3162332033231100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-31)
62332-332-91623320332911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-91)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ac18e5fa-e2ee-4aa5-8d0f-94b63a076e66

Use it

Look up 62332-332 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/62332-332 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 62332-332. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.